HDAC6 inhibitors as a treatment for Rett syndrome: Resolving neuronal trafficking deficits
- Research Opportunity
- Project Status
- Royal Melbourne Hospital
|Professor John Christodoulou||Personal web page|
|Dr Nicole Van Bergen||Personal web page|
We hypothesize that correcting the cytoskeletal defect in MECP2-deficient neuronal cells using HDAC6 inhibitors that correct the is cytoskeletal defect could underlie a therapeutic solution for Rett syndrome.
Faculty Research Themes
School Research Themes
Graduate Research Students who are interested in joining this project will need to consider their elegibility as well as other Graduate Research requirements before contacting the supervisor of this research
For further information about this research, please contact a supervisor.